Drug Shortage Report for PRALUENT
Report ID | 80305 |
Drug Identification Number | 02453819 |
Brand name | PRALUENT |
Common or Proper name | Praluent Pen 75mg/mL |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ALIROCUMAB |
Strength(s) | 75MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | 2 pre-filled pens |
ATC code | C10AX |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2019-04-15 |
Actual start date | |
Estimated end date | 2019-05-06 |
Actual end date | 2019-04-17 |
Shortage status | Resolved |
Updated date | 2019-04-18 |
Company comments | TEMPORARY SHORTAGE OF PRALUENT, 75mg/mL & 150mg/mL (Alirocumab) We recognize the difficulties that this situation may cause for patients and health care providers. We apologize for any inconvenience resulting from this. Please note that both strengths (75 mg/mL and 150mg/mL) are not equivalent. For more information, please contact your healthcare professional. All efforts are being made to resolve the situation and any update will be communicated on the www.drugshortagescanada.ca website. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-04-02 | English | Compare |
v2 | 2019-04-02 | French | Compare |
v3 | 2019-04-16 | English | Compare |
v4 | 2019-04-18 | English | Compare |
v5 | 2019-04-18 | French | Compare |
Showing 1 to 5 of 5